C3 and coronary artery disorder: Complement C3 is associated with an adverse lipoprotein profile distinguished by an increase in triglyceride-enriched lipoproteins and a reduction in large HDL particles (29); reduced levels of large HDL particles has been associated with increased CHD risk (30).